Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 13/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13623366 | 0.81 | ERN1 (0.58) | ERN1PIM1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL14031706 | 0.81 | ERN1 (0.58) | ERN1PIM1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL11870495 | 0.80 | ALDH1A1 (0.41) | ERN1GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL30705750 | 0.78 | ERN1 (0.65) | ERN1PIM1 | |
| SCHEMBL27963619 | 0.77 | ALDH1A1 (0.39) | ERN1GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL23268461 | 0.76 | ERN1 (0.52) | ERN1GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL6843112 | 0.76 | ERN1 (0.34) | ERN1GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL8436582 | 0.73 | ERN1 (0.54) | ERN1PIM1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5848639 | 0.73 | ALDH1A1 (0.46) | ALDH1A1TSHRTP53CYP3A4TDP1 | |
| SCHEMBL7651200 | 0.73 | ALDH1A1 (0.38) | ERN1GRIA1GRIA2GRIA3GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | HENKEL AG & CO. KGAA (DE) | 2024-03-05 | — | — | US | claimed |
| US-6770102-B1 | AROMATIC ALDEHYDES OR KETONES AND CH-ACTIVE COMPOUNDS; DOES NOT REQUIRE OXIDIZING AGENT; BRILLIANCE; COLOR DEPTH; WIDE VARIETY OF SHADES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-08-03 | — | — | US | disclosed |
| US-4260776-A | PYRAZOLONE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | TYR, HAO2, HAAO | ERN1 4459/4885GRIA1 1452/4885GRIA2 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.